{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18(1)"],"submitter":["Drozdoff L"],"funding":["Technische Universität München","Deutsche Forschungsgemeinschaft"],"pubmed_abstract":["<h4>Background</h4>Biologically-based complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy.<h4>Methods</h4>From September 2014 to December 2014 and February 2017 to May 2017 all patients (n= 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on complementary medication intake during systemic therapy.<h4>Results</h4>Among 448 respondents 74.1% report"],"journal":["BMC complementary and alternative medicine"],"pagination":["259"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6154925"],"repository":["biostudies-literature"],"pubmed_title":["Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy."],"pmcid":["PMC6154925"],"pubmed_authors":["Klein E","Drozdoff L","Paepke D","Kiechle M"],"additional_accession":[]},"is_claimable":false,"name":"Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.","description":"<h4>Background</h4>Biologically-based complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy.<h4>Methods</h4>From September 2014 to December 2014 and February 2017 to May 2017 all patients (n= 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on complementary medication intake during systemic therapy.<h4>Results</h4>Among 448 respondents 74.1% report","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Sep","modification":"2026-05-06T04:08:24.063Z","creation":"2026-04-07T22:15:15.308Z"},"accession":"S-EPMC6154925","cross_references":{"pubmed":["30249217"],"doi":["10.1186/s12906-018-2325-3"]}}